Since its foundation in 2004, the Institute for Hematopathology Hamburg, Germany, has established itself as a fixture in the German healthcare system. From the very beginning, our mission has been to actively shape the diagnostic landscape and turn scientific progress into clinical practice for the benefit of the patient. Our diagnostic range covers leukemia, lymphoma and solid tumors, as well as benign hematologic and lymphatic disorders. To provide hematologists and oncologists with the best possible support when making therapy decisions, more than 300 employees ensure diagnostics are performed quickly, reliably and to the highest quality standards. Our portfolio hereby includes histology, cytomorphology, immunohistochemistry and immunophenotyping as well as comprehensive NGS-based molecular diagnostics and bioinformatics analysis of complex biomarkers. Innovative technologies such as digital pathology and artificial intelligence further strengthen our diagnostics capabilities. As a fast growing company in a rapidly evolving field, our goal as a team is to continue to make a significant contribution to the improvement of patient care.